Alcon Current Ratio 2019-2024 | ALC
Current and historical current ratio for Alcon (ALC) from 2019 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Alcon current ratio for the three months ending September 30, 2024 was 2.57.
| Alcon Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $6.32B | $2.46B | 2.57 |
| 2024-06-30 | $5.99B | $2.34B | 2.56 |
| 2024-03-31 | $5.70B | $2.27B | 2.51 |
| 2023-12-31 | $5.65B | $2.40B | 2.36 |
| 2023-09-30 | $5.55B | $2.51B | 2.21 |
| 2023-06-30 | $5.20B | $2.41B | 2.16 |
| 2023-03-31 | $5.33B | $2.60B | 2.05 |
| 2022-12-31 | $5.19B | $2.74B | 1.90 |
| 2022-09-30 | $5.16B | $2.33B | 2.21 |
| 2022-06-30 | $5.02B | $2.32B | 2.16 |
| 2022-03-31 | $4.89B | $2.25B | 2.18 |
| 2021-12-31 | $5.39B | $2.47B | 2.18 |
| 2021-09-30 | $5.29B | $2.38B | 2.23 |
| 2021-06-30 | $5.02B | $2.20B | 2.28 |
| 2021-03-31 | $4.97B | $1.97B | 2.53 |
| 2020-12-31 | $4.99B | $2.26B | 2.21 |
| 2020-09-30 | $4.78B | $2.09B | 2.29 |
| 2020-06-30 | $4.63B | $2.08B | 2.23 |
| 2020-03-31 | $4.13B | $2.13B | 1.93 |
| 2019-12-31 | $4.24B | $2.30B | 1.84 |
| 2019-09-30 | $4.22B | $2.25B | 1.88 |
| 2019-06-30 | $4.14B | $3.82B | 1.09 |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.291B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.813B | 24.50 |
| Intuitive Surgical (ISRG) | United States | $194.018B | 101.44 |
| Edwards Lifesciences (EW) | United States | $43.628B | 27.70 |
| IQVIA Holdings (IQV) | United States | $36.367B | 20.04 |
| IDEXX Laboratories (IDXX) | United States | $35.798B | 42.16 |
| DexCom (DXCM) | United States | $30.830B | 46.43 |
| Waters (WAT) | United States | $22.743B | 33.63 |
| STERIS (STE) | Ireland | $21.361B | 24.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.498B | 0.00 |
| Hologic (HOLX) | United States | $17.041B | 18.40 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.902B | 14.27 |
| Sysmex ADR (SSMXY) | Japan | $12.298B | 38.57 |
| Globus Medical (GMED) | United States | $11.262B | 28.52 |
| Penumbra (PEN) | United States | $9.682B | 94.83 |
| Masimo (MASI) | United States | $9.374B | 45.36 |
| Teleflex (TFX) | United States | $8.514B | 13.58 |
| Glaukos (GKOS) | United States | $7.737B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.687B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.672B | 26.48 |
| Veracyte (VCYT) | United States | $3.441B | 103.26 |
| Inari Medical (NARI) | United States | $3.299B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.830B | 16.33 |
| Nihon Kohden (NHNKY) | Japan | $2.541B | 19.30 |
| Tandem Diabetes Care (TNDM) | United States | $2.253B | 0.00 |
| TransMedics (TMDX) | United States | $2.205B | 69.90 |
| Elekta AB (EKTAY) | Sweden | $2.177B | 19.57 |
| Integra LifeSciences Holdings (IART) | United States | $1.870B | 9.77 |
| RxSight (RXST) | United States | $1.447B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.376B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 81.94 |
| OPKO Health (OPK) | United States | $1.099B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.054B | 0.00 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.847B | 14.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.691B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.691B | 16.28 |
| IRadimed (IRMD) | United States | $0.690B | 37.28 |
| AxoGen (AXGN) | United States | $0.634B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.595B | 35.04 |
| SiBone (SIBN) | United States | $0.571B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.560B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.475B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.435B | 23.55 |
| Delcath Systems (DCTH) | United States | $0.377B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.326B | 0.00 |
| CVRx (CVRX) | United States | $0.325B | 0.00 |
| Inogen (INGN) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.193B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.189B | 0.00 |
| Nevro (NVRO) | United States | $0.158B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.145B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.139B | 14.90 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| LENSAR (LNSR) | United States | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| 908 Devices (MASS) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.050B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| NexGel (NXGL) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.010B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |